News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunomedics, Inc. (IMMU) Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2012 Financial Results


8/10/2012 9:30:04 AM

MORRIS PLAINS, N.J., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a conference call and live audio webcast on Friday, August 24, 2012 at 10:00 a.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year 2012, and review key clinical developments and future planned activities.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES